Cargando…

Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike

Receptor-ligand interactions on the plasma membrane regulate cellular communication and play a key role in viral infection. Despite representing main targets for drug development, the characterization of these interactions remains challenging in part due to the dearth of optimal technologies. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husain, Bushra, Yuen, Kobe, Sun, Dawei, Cao, Shengya, Payandeh, Jian, Martinez-Martin, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355963/ https://www.ncbi.nlm.nih.gov/pubmed/35931765 http://dx.doi.org/10.1038/s42003-022-03695-0

Ejemplares similares

The Host Interactome of Spike Expands the Tropism of SARS-CoV-2
por: Bamberger, Casimir, et al.
Publicado: (2021)

A membrane protein display platform for receptor interactome discovery
por: Cao, Shengya, et al.
Publicado: (2021)

Evolution of the SARS-CoV-2 spike protein in the human host
por: Wrobel, Antoni G., et al.
Publicado: (2022)

Identifying and profiling structural similarities between Spike of SARS-CoV-2 and other viral or host proteins with Machaon
por: Kakoulidis, Panos, et al.
Publicado: (2023)

Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors
por: Zhang, Yuan, et al.
Publicado: (2007)

SPIKES: Identification of physicochemical properties of spike proteins across diverse host species of SARS-CoV-2
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
por: Ko, Karrie K. K., et al.
Publicado: (2022)

Site-specific glycan analysis of the SARS-CoV-2 spike
por: Watanabe, Yasunori, et al.
Publicado: (2020)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2020)

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
por: Pomplun, Sebastian, et al.
Publicado: (2020)

Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
por: Wang, Lin, et al.
Publicado: (2021)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2021)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate
por: Su, Rui, et al.
Publicado: (2022)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
por: Yu, Shi, et al.
Publicado: (2023)

Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
por: Su, Rui, et al.
Publicado: (2023)

Identifying zoonotic origin of SARS-CoV-2 by modeling the binding affinity between Spike receptor-binding domain and host ACE2
por: Huang, Xiaoqiang, et al.
Publicado: (2020)

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
por: Allen, Joel D., et al.
Publicado: (2021)

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
por: Wang, Ke, et al.
Publicado: (2020)

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential
por: Mullen, Tracey E, et al.
Publicado: (2021)

Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display
por: Norman, Alexander, et al.
Publicado: (2021)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery
por: Mohebbi, Alireza, et al.
Publicado: (2021)

In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein
por: Wang, Qing, et al.
Publicado: (2023)

2636. Discovery of Spike Identification (SpiID) Nanobody Panel for SARS-CoV-2 Vaccine Development
por: Li, Qi, et al.
Publicado: (2023)

Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
por: Lu, Guangwen, et al.
Publicado: (2015)

Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
por: Flynn, Ryan A., et al.
Publicado: (2021)

The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy
por: Santopolo, Silvia, et al.
Publicado: (2021)

Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
por: Martinez-Martin, Nadia
Publicado: (2017)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

SARS-CoV-2 spike gene Sanger sequencing methodology to identify variants of concern
por: Alhamlan, Fatimah S, et al.
Publicado: (2023)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
por: Herrlein, Marie-Luise, et al.
Publicado: (2022)

Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
por: Zhang, Bao-zhong, et al.
Publicado: (2020)

Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2
por: Peng, Qiaoli, et al.
Publicado: (2022)

SAS: A Platform of Spike Antigenicity for SARS-CoV-2
por: Zhang, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0helfggqb42r5cba549mu252vo